Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Dr. Prem Aggarwal

Dr Prem Aggarwal, (MD Medicine, DNB Cardiology) is a Cardiologist by profession and also the Co-founder and Chairman of Medical. He focuses on news and perspectives about cardiology, and medicine related developments at Medical Dialogues. He can be reached out at drprem@medicaldialogues.in

Home

Dr. Prem Aggarwal

Articles By : Dr. Prem Aggarwal

Effective BP control: High dose ARB monotherapy or combination therapy of ARB and CCB for hypertension?

Dr. Prem Aggarwal10 Oct 2020 10:30 AM IST

Hypertension (HTN) is a global health hazard and a leading cause of mortality and morbidity. It is ranked third as a cause for disability-adjusted...

Acid suppressants in Cardiac Patients: Sneak Peak of Clinical Guidelines

Dr. Prem Aggarwal25 Sept 2020 11:02 AM IST

Cardiovascular diseases (CVD) encompass a range of congenital or acquired pathological conditions that affect the structure or function of the heart,...

Effects of Azelnidipine versus Amlodipine on LV Mass and Longitudinal Function in Hypertensive Patients with LVH

Dr. Prem Aggarwal19 Sept 2020 11:00 AM IST

Left ventricular hypertrophy (LVH) is the structural remodelling of the heart which is a serious consequence of systemic hypertension. It is a...

Growing role of Cadexomer Iodine in wound care: Review

Dr. Prem Aggarwal17 Sept 2020 11:30 AM IST

Iodine, a natural element of the halogen group, is an essential nutrient in the body. It possesses antiseptic properties and hence has been used...

Evidence-based review on the incidence of ACEIs induced cough published in Indian Heart Journal

Dr. Prem Aggarwal16 Sept 2020 11:45 AM IST

New Delhi: Angiotensin-converting enzyme inhibitors (ACEIs) are most often prescribed as the first-line treatment modality in hypertensive patients....

Amlodipine and its Efficiency in Cardioprotection: Review

Dr. Prem Aggarwal7 Sept 2020 12:45 PM IST

Cardiovascular diseases (CVD) are the leading causes of death worldwide (1). As per Lancet's Global Burden of Disease Study 1990–2016 in India,...

Cadexomer Iodine Treatment of Diabetic Foot Ulcers

Dr. Prem Aggarwal2 Sept 2020 12:47 PM IST

Diabetes is a chronic, metabolic disease characterized by increased levels of blood sugar. According to WHO, about 422 million people worldwide are...

Impact of Azelnidipine treatment on left ventricular diastolic performance in patients with BP and mild diastolic dysfunction: CALVLOC trial

Dr. Prem Aggarwal28 Aug 2020 12:30 PM IST

One of the most common forms of heart failure is Left Ventricular Diastolic Dysfunction. Patients with hypertension are at particular risk of heart...

COVID-19, Gut and Potential Role of Probiotics

Dr. Prem Aggarwal25 Aug 2020 11:50 AM IST

Coronavirus disease 2019 (COVID-19) - an international public health emergency declared by the World Health Organization [1], has massively spread...

Amlodipine and Cardiovascular outcomes in Hypertensive patients: What Meta-analysis says

Dr. Prem Aggarwal17 Aug 2020 12:30 PM IST

A major risk factor for cardiovascular disease is hypertension. A multitude of drugs, including calcium channel blockers (CCBs), β-blockers,...

Controlling Variability in Home Blood Pressure: Which Combination therapy is better?

Dr. Prem Aggarwal11 Aug 2020 12:53 PM IST

Hypertension is one of the most preventable causes of death worldwide that accounts for more than 12.8% of all deaths annually. Elevated blood...

Doxycycline in COVID-19: How a Veteran Antibiotic Stands Out?!!

Dr. Prem Aggarwal7 Aug 2020 11:57 AM IST

Doxycycline in COVID-19: How a Veteran Antibiotic Stands Out?!!

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok